These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 24824420)
1. COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours. Millanta F; Asproni P; Canale A; Citi S; Poli A Vet Comp Oncol; 2016 Sep; 14(3):270-80. PubMed ID: 24824420 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of COX-2, mPGES and EP2 receptor in normal and reactive canine bone and in canine osteosarcoma. Millanta F; Asproni P; Cancedda S; Vignoli M; Bacci B; Poli A J Comp Pathol; 2012; 147(2-3):153-60. PubMed ID: 22633646 [TBL] [Abstract][Full Text] [Related]
3. EP2/4 Receptors Promote the Synthesis of PGE Zhang C; Wang L; Li T; Mao W; Liu B; Cao J J Pharmacol Exp Ther; 2020 Feb; 372(2):175-184. PubMed ID: 31732699 [TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of feline COX-2 and expression in feline mammary carcinomas. Sayasith K; Sirois J; Doré M Vet Pathol; 2009 May; 46(3):423-9. PubMed ID: 19176489 [TBL] [Abstract][Full Text] [Related]
5. Low E-prostanoid 2 receptor levels and deficient induction of the IL-1β/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated respiratory disease. Machado-Carvalho L; Martín M; Torres R; Gabasa M; Alobid I; Mullol J; Pujols L; Roca-Ferrer J; Picado C J Allergy Clin Immunol; 2016 Jan; 137(1):99-107.e7. PubMed ID: 26560040 [TBL] [Abstract][Full Text] [Related]
6. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome. Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215 [TBL] [Abstract][Full Text] [Related]
7. Metallothionein expression in canine and feline mammary and melanotic tumours. Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128 [TBL] [Abstract][Full Text] [Related]
8. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours. Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094 [TBL] [Abstract][Full Text] [Related]
9. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer. Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848 [TBL] [Abstract][Full Text] [Related]
11. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892 [TBL] [Abstract][Full Text] [Related]
12. Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells. Wang LS; Huang YW; Liu S; Chang HL; Ye W; Shu S; Sugimoto Y; Funk JA; Smeaks DD; Hill LN; Lin YC Anticancer Res; 2006; 26(2A):889-98. PubMed ID: 16619484 [TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase-2 in neoplasms of the mammary gland in bitches. Badowska-Kozakiewicz AM; Malicka E Pol J Vet Sci; 2010; 13(2):337-42. PubMed ID: 20731190 [TBL] [Abstract][Full Text] [Related]
15. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade. Anadol E; Yar Saglam AS; Gultiken N; Karakas K; Alcigir E; Alkan H; Kanca H Acta Vet Hung; 2017 Sep; 65(3):382-393. PubMed ID: 28956485 [TBL] [Abstract][Full Text] [Related]
16. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival. Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908 [TBL] [Abstract][Full Text] [Related]
17. mPGES-1-Derived PGE2 Contributes to Indoxyl Sulfate-Induced Mesangial Cell Proliferation. Li S; Sun Z; Ding G; Gong W; Yu J; Xia W; Huang S; Zhang A; Zhang Y; Jia Z Cell Physiol Biochem; 2017; 43(1):271-281. PubMed ID: 28854439 [TBL] [Abstract][Full Text] [Related]
18. Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages. Díaz-Muñoz MD; Osma-García IC; Fresno M; Iñiguez MA Biochem J; 2012 Apr; 443(2):451-61. PubMed ID: 22268508 [TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts. Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087 [TBL] [Abstract][Full Text] [Related]
20. Temporal expression of the PGE2 synthetic system in the kidney is associated with the time frame of renal developmental vulnerability to cyclooxygenase-2 inhibition. Frölich S; Olliges A; Kern N; Schreiber Y; Narumiya S; Nüsing RM Am J Physiol Renal Physiol; 2012 Jul; 303(2):F209-19. PubMed ID: 22573380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]